Aethlon Medical
AEMD
6 hedge funds and large institutions have $1.98M invested in Aethlon Medical in 2016 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, reducing their positions, and 2 closing their positions.
14% less funds holding
Funds holding: 7 → 6 (-1)
26% less capital invested
Capital invested by funds: $2.7M → $1.98M (-$715K)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
Top Sellers
| 1 |
Bank of New York Mellon
New York
|
-$111K |
| 2 |
Northern Trust
Chicago,
Illinois
|
-$77K |
| 3 |
US Bancorp
Minneapolis,
Minnesota
|
-$4K |
AEMD Hedge Fund Activity: Q1 2016 in Review
6 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q1 2016, worth a combined $1.98M — down 26% from $2.7M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of AEMD and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Bank of New York Mellon, exiting entirely with an estimated $111K sold.
- 6 institutional investors held Aethlon Medical (AEMD) as of Q1 2016, down from 7 in Q4 2015.
- Funds reported $1.98M of Aethlon Medical stock for Q1 2016, down 26% quarter-over-quarter.
- 1 fund opened new Aethlon Medical positions in Q1 2016 and 2 closed out, a net change of -1 holder.
- The largest Aethlon Medical seller in Q1 2016 was Bank of New York Mellon, an estimated $111K sold.
Based on aggregated 13F filings for Q1 2016.